搜尋結果
Lu, S. H. ,
Hsu, W. L. ,
Chen, T. H. &
Chou, T. C. ,
12月 1 2015 ,
於: International Immunopharmacology. 29 ,
2 ,
p. 770-778 9 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
magnolol
100%
Porphyromonas gingivalis
74%
Heme Oxygenase-1
60%
Lipopolysaccharides
51%
Anti-Inflammatory Agents
44%
Lin, H. ,
Sue, Y. M. ,
Chou, Y. ,
Cheng, C. F. ,
Chang, C. C. ,
Li, H. F. ,
Chen, C. C. &
Juan, S. H. ,
12月 2010 ,
於: British Journal of Pharmacology. 161 ,
7 ,
p. 1661-1676 16 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Carboplatin
100%
Oxidative Stress
65%
T-Lymphocytes
55%
Apoptosis
54%
Kidney
47%
Lin, H. ,
Li, H. F. ,
Chen, H-H. ,
Lai, P. F. ,
Juan, S-H. ,
Chen, J. J. &
Cheng, C. F. ,
2014 ,
於: Molecular Pharmacology. 85 ,
5 ,
p. 682-691 10 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Activating Transcription Factor 3
100%
Beclin-1
80%
Autophagy
60%
Heart Failure
46%
Pressure
40%
Peng, C. C. ,
Liu, J. H. ,
Chang, C. H. ,
Chung, J. Y. ,
Chen, K. C. ,
Chou, K. Y. &
Peng, R. Y. ,
2013 ,
於: Evidence-based Complementary and Alternative Medicine. 2013 , 408734.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Ginkgo biloba extract
100%
Ginkgo biloba
99%
Exercise Therapy
85%
Prostatic Hyperplasia
67%
Hyperplasia
62%
Chen, K. C. ,
Peng, C. C. ,
Chiu, W. T. ,
Cheng, Y. T. ,
Huang, G. T. ,
Hsieh, C. L. &
Peng, R. Y. ,
2月 2010 ,
於: Nutrition and Cancer. 62 ,
2 ,
p. 260-270 11 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Psidium
100%
Prostatic Neoplasms
48%
Signal Transduction
48%
Prostate-Specific Antigen
42%
Metribolone
32%
Chang, K. Y. ,
Chen, Y. C. ,
Yeh, S. C. ,
Kao, C. C. ,
Cheng, C. Y. ,
Kang, Y. N. &
Huang, C. W. ,
3月 1 2022 ,
於: Nutrients. 14 ,
6 , 1250.
研究成果: 雜誌貢獻 › 文章 › 同行評審
omega-6 fatty acids
100%
high density lipoprotein
98%
low density lipoprotein
95%
dialysis
87%
LDL Lipoproteins
87%
Maeda, K. ,
Shigemura, K. ,
Fang, S-B. ,
Yang, Y. ,
Chiang, Y-T. ,
Sung, S-Y. ,
Chen, K-C. ,
Nakano, Y. ,
Miyara, T. &
Fujisawa, M. ,
2023 ,
於: International Journal of Urology. 30 ,
1 ,
p. 43-49 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Wang, C. C. ,
Sue, Y. M. ,
Yang, C. H. &
Chen, C. K. ,
5月 2006 ,
於: Journal of the American Academy of Dermatology. 54 ,
5 ,
p. 804-810 7 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Lentigo
100%
Melanosis
90%
Solid-State Lasers
75%
Lasers
54%
Light
47%
Lin, L. Y. ,
Peng, R. Y. ,
Peng, C. C. ,
Wang, H. E. ,
Chuang, C. M. ,
Yu, T. H. ,
Chen, K. C. &
Chiu, W. T. ,
2008 ,
於: Food and Bioprocess Technology. 1 ,
3 ,
p. 234-245 12 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Sorghum
100%
nanogold
85%
Acetic acid
77%
Acetic Acid
64%
Acceleration
58%
Spontaneous Coronary Artery Dissection
100%
Stents
54%
Coronary Angiography
37%
Optical Coherence Tomography
25%
Hematoma
23%
Kao, W-T. ,
Shen, C-H. ,
Kiu, K-T. ,
Chen, H-A. ,
Wu, C-C. &
Wang, Y-H. ,
8月 1 2015 ,
於: Cancer Research. 75 ,
15 Supplement 研究成果: 雜誌貢獻 › 文章 › 同行評審
Lin, Y. C. ,
Lin, Y. C. ,
Chen, T-W. ,
Yang, W. C. &
Lin, C. C. ,
2月 2012 ,
於: Journal of the Chinese Medical Association. 75 ,
2 ,
p. 54-59 6 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Peritoneal Dialysis
100%
Longitudinal Studies
76%
Thyroid Gland
76%
Mortality
46%
C-Reactive Protein
17%
Liao, C. T. ,
Zheng, C. M. ,
Lin, Y. C. ,
Wu, M. Y. ,
Lin, Y. F. ,
Hsu, Y. H. ,
Hsu, C. C. &
Wu, M. S. ,
1月 13 2021 ,
於: Scientific Reports. 11 ,
1 , 1171.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Peritoneal Dialysis
100%
Phosphorus
97%
Peritonitis
94%
Parathyroid Hormone
92%
Calcium
63%
Lin, Y. Y. ,
Hsu, Y. H. ,
Huang, H. Y. ,
Shann, Y. J. ,
Huang, C. Y. F. ,
Wei, S. C. ,
Chen, C. L. &
Jou, T. S. ,
5月 1 2012 ,
於: Journal of Clinical Investigation. 122 ,
5 ,
p. 1881-1894 14 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Mouse Hnf1a protein
100%
Catenins
59%
Phosphoproteins
55%
T Cell Transcription Factor 1
53%
Carcinogenesis
36%
Wu, C. C. ,
Chen, J. S. ,
Lu, K. C. ,
Chen, C. C. ,
Lin, S. H. ,
Chu, P. ,
Sytwu, H. K. &
Lin, Y. F. ,
2010 ,
於: Clinica Chimica Acta. 411 ,
9-10 ,
p. 700-704 5 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Diabetic Nephropathies
100%
Proteinuria
90%
Chemokines
88%
Cytokines
58%
Plasma
34%
Chen, Y-L. ,
Wu, Y-N. ,
Liao, C-H. ,
Lin, Y-H. ,
Wu, C-C. &
Chiang, H-S. ,
2014 ,
於: Translational Andrology and Urology. 3 ,
0 研究成果: 雜誌貢獻 › 文章 › 同行評審
Chen, Y-L. ,
Wu, Y-N. ,
Liao, C-H. ,
Lin, Y-H. ,
Wu, C-C. &
Chiang, H-S. ,
2014 ,
於: Translational Andrology and Urology. 3 ,
0 研究成果: 雜誌貢獻 › 文章 › 同行評審
Lin, Y. W. ,
Lien, L. M. ,
Yeh, T. S. ,
Wu, H. M. ,
Liu, Y. L. &
Hsieh, R. H. ,
12月 12 2008 ,
於: Biochemical and Biophysical Research Communications. 377 ,
2 ,
p. 351-354 4 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
9-Cis-Retinoic Acid
100%
Alitretinoin
90%
Retinoid X Receptors
82%
Retinoid
79%
Mitochondria
50%
Chang, C. H. C. ,
Chen, K-K. ,
Lin, T. L. ,
Pan, C-C. ,
Chang, Y-H. ,
Huang, J. ,
Kuo, J-Y. ,
Chung, H-J. &
Lin, T. L. ,
4月 1 2015 ,
於: European Urology, Supplements. 14 ,
2 ,
p. e836 研究成果: 雜誌貢獻 › 文章 › 同行評審
Liu, M. ,
Bamodu, O. A. ,
Huang, W. C. ,
Zucha, M. A. ,
Lin, Y. K. ,
Wu, A. T. H. ,
Huang, C. C. ,
Lee, W. H. ,
Yuan, C. C. ,
Hsiao, M. ,
Deng, L. ,
Tzeng, Y. M. &
Yeh, C. T. ,
3月 15 2017 ,
於: Toxicology and Applied Pharmacology. 325 ,
p. 48-60 13 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
4-acetylantroquinonol B
100%
Cisplatin
47%
Phosphatidylinositol 3-Kinases
43%
Autophagy
42%
Hydroxychloroquine
26%
Chen, K. Y. ,
Tseng, C. H. ,
Feng, P. H. ,
Sun, W. L. ,
Ho, S. C. ,
Lin, C. W. ,
Van Hiep, N. ,
Luo, C. S. ,
Tseng, Y. H. ,
Chen, T. T. ,
Liu, W. T. ,
Lee, K. Y. &
Wu, S. M. ,
2022 ,
於: Cell Biology and Toxicology. 38 ,
5 ,
p. 865-887 23 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
benzanthrone
100%
Epiregulin
80%
Clonogenic
36%
Epithelial Cells
34%
Environmental Contaminant
31%
Chang, C-C. ,
Hsu, Y-H. ,
Chou, H-C. ,
Lee, Y-C. G. &
Juan, S-H. ,
5月 1 2017 ,
於: Journal of Cellular Physiology. 232 ,
5 ,
p. 1020-1029 研究成果: 雜誌貢獻 › 文章 › 同行評審
3-Methylcholanthrene
100%
Aryl Hydrocarbon Receptors
89%
Methylcholanthrene
88%
Nitric Oxide Synthase Type III
79%
Hypertension
45%
Chang, C. C. ,
Sue, Y. M. ,
Yang, N. J. ,
Lee, Y-H. &
Juan, S. H. ,
3月 21 2014 ,
於: PLoS One. 9 ,
3 , e92793.
研究成果: 雜誌貢獻 › 文章 › 同行評審
Aryl Hydrocarbon Receptor Agonist
100%
Histone Deacetylase 1
84%
3-Methylcholanthrene
79%
histone deacetylase
77%
cell cycle checkpoints
73%
Huang, W. H. ,
Teng, L. C. ,
Yeh, T. K. ,
Chen, Y. J. ,
Lo, W. J. ,
Wu, M. J. ,
Chin, C. S. ,
Tsan, Y. T. ,
Lin, T. C. ,
Chai, J. W. ,
Lin, C. F. ,
Tseng, C. H. ,
Liu, C. W. ,
Wu, C. M. ,
Chen, P. Y. ,
Shi, Z. Y. &
Liu, P. Y. ,
6月 2020 ,
於: Journal of Microbiology, Immunology and Infection. 53 ,
3 ,
p. 481-484 4 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Coronavirus
100%
Taiwan
78%
China
64%
Severe Acute Respiratory Syndrome
51%
Clinical Laboratory Techniques
44%
Calcitriol
100%
Cathepsins
76%
Peptide Hydrolases
71%
Prostatic Neoplasms
67%
Tissue Inhibitor of Metalloproteinase-1
51%
Tsai, Y. J. ,
Lin, Y. H. ,
Hsu, C-H. &
Yeh, S-D. ,
7月 2013 ,
於: Clinical Imaging. 37 ,
4 ,
p. 791-793 3 p. 研究成果: 雜誌貢獻 › 文章 › 同行評審
Histoplasmosis
100%
Fluorodeoxyglucose F18
78%
Positron-Emission Tomography
69%
Therapeutics
12%
Juan, S. H. ,
Chen, J. J. ,
Chen, C. H. ,
Lin, H. ,
Cheng, C. F. ,
Liu, J. C. ,
Hsieh, M. H. ,
Chen, Y. L. ,
Chao, H. H. ,
Chen, T. H. ,
Chan, P. &
Cheng, T-H. ,
9月 2004 ,
於: American Journal of Physiology - Heart and Circulatory Physiology. 287 ,
3 56-3 ,
p. H1254-H1261 研究成果: 雜誌貢獻 › 文章 › 同行評審
Endothelin-1
100%
Endothelial Cells
68%
Gene Expression
55%
Extracellular Signal-Regulated MAP Kinases
37%
2-(2-(2-chloro-3-(2-(3,3-dimethyl-5-sulfo-1-(4-sulfo-butyl)-3H-indol-2-yl)-vinyl)-cyclohex-2-enylidene)-ethylidene)-3,3-dimethyl-1-(4-sulfo-butyl)-2,3-dihydro-1H-indole-5-carboxylic acid
18%
Liang, Y. C. ,
Chuang, M. T. ,
Ho, F. M. ,
Wu, C. C. ,
Zhuang, S. Y. ,
Lin, S. Y. &
Suk, F. M. ,
2011 ,
於: Evidence-based Complementary and Alternative Medicine. 2011 , 865435.
研究成果: 雜誌貢獻 › 文章 › 同行評審
15,16-dihydrotanshinone I
100%
Salvia miltiorrhiza
65%
Prostate
39%
Carcinoma
31%
Apoptosis
28%
Penile Implantation
100%
Patient Satisfaction
29%
Penile Prosthesis
22%
Equipment and Supplies
18%
Survival
17%